These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19998203)

  • 1. Control theory: placebo-controlled drug trials have problems. Active-controlled drug trials are not always the solution.
    Golomb BA
    Am J Bioeth; 2009 Sep; 9(9):67-9. PubMed ID: 19998203
    [No Abstract]   [Full Text] [Related]  

  • 2. The rationale for placebo-controlled trials: methodology and policy considerations.
    Miller FG
    Am J Bioeth; 2009 Sep; 9(9):49-50. PubMed ID: 19998193
    [No Abstract]   [Full Text] [Related]  

  • 3. Questioning the methodological superiority of 'placebo' over 'active' controlled trials.
    Enkin MW
    Am J Bioeth; 2009 Sep; 9(9):66-7. PubMed ID: 19998202
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethical issues in the difference between placebo-controlled and active-controlled trials.
    Petrini C
    Am J Bioeth; 2009 Sep; 9(9):56-8. PubMed ID: 19998197
    [No Abstract]   [Full Text] [Related]  

  • 5. Research, medicine, and "placebos".
    Moerman DE
    Am J Bioeth; 2009 Sep; 9(9):64-5. PubMed ID: 19998201
    [No Abstract]   [Full Text] [Related]  

  • 6. Strengthening Howick's argument against the alleged superiority of placebo-controlled trials.
    Rennie S; Stürmer T
    Am J Bioeth; 2009 Sep; 9(9):62-4. PubMed ID: 19998200
    [No Abstract]   [Full Text] [Related]  

  • 7. Placebo misconceptions.
    Senn S
    Am J Bioeth; 2009 Sep; 9(9):53-4. PubMed ID: 19998195
    [No Abstract]   [Full Text] [Related]  

  • 8. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.
    Howick J
    Am J Bioeth; 2009 Sep; 9(9):34-48. PubMed ID: 19998192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparing for a post-placebo paradigm: ethics and choice of control in clinical trials.
    Nunn R
    Am J Bioeth; 2009 Sep; 9(9):51-2. PubMed ID: 19998194
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conflating scientific with clinical considerations.
    van der Graaf R; van Delden JJ
    Am J Bioeth; 2009 Sep; 9(9):58-9. PubMed ID: 19998198
    [No Abstract]   [Full Text] [Related]  

  • 13. Who's in control of the choice of control?
    Anderson JA
    Am J Bioeth; 2009 Sep; 9(9):60-2. PubMed ID: 19998199
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical perspective on placebo research: looking back, looking forward.
    Dworkin RW
    Am J Bioeth; 2009 Sep; 9(9):54-5. PubMed ID: 19998196
    [No Abstract]   [Full Text] [Related]  

  • 15. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
    Carroll KJ
    Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovation and placebos in research: a new design of clinical trial.
    Holbrook A; Goldsmith C
    Lancet; 2003 Dec; 362(9401):2036-7. PubMed ID: 14697799
    [No Abstract]   [Full Text] [Related]  

  • 17. The powerful placebo: doubting the doubters.
    Greene PJ; Wayne PM; Kerr CE; Weiger WA; Jacobson E; Goldman P; Kaptchuk TJ
    Adv Mind Body Med; 2001; 17(4):298-307; discussion 312-8. PubMed ID: 11931055
    [No Abstract]   [Full Text] [Related]  

  • 18. Historical data in the design and interpretation of trials with newly diagnosed patients.
    Baulac M
    Epilepsy Res; 2006 Jan; 68(1):77-81. PubMed ID: 16377145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pros and cons of noninferiority trials.
    Pocock SJ
    Fundam Clin Pharmacol; 2003 Aug; 17(4):483-90. PubMed ID: 12914552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dilemma of placebo controlled studies: scientific evidence, guidelines, ethics and regulatory recommendations.
    Zanchetti A; Mancia G
    J Hypertens; 2009 Jan; 27(1):1-2. PubMed ID: 19050441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.